| MODERNA INC. DL-,0001 |
| USA |
| Gesundheit |
| US60770K1079 / A2N9D9 |
| 0QF (Frankfurt) / MRNA (NASDAQ) |
| FRA:0QF, ETR:0QF, 0QF:GR, NASDAQ:MRNA |
| S&P500 |
| https://www.modernatx.com.. |
|
Moderna, Inc. is a biotechnology company specializing in the research, development, and provision of messenger RNA (mRNA) medicines in the United States, Europe, and internationally. Its primary function centers on creating innovative therapeutics an..
>Volltext.. |
| 15351.86 Mio. EUR |
| 11967.17 Mio. EUR |
| 1898.38 Mio. EUR |
| -2710.64 Mio. EUR |
| -2725.14 Mio. EUR |
| -6.95 EUR |
| 1107.46 Mio. EUR |
| 1627.92 Mio. EUR |
| -1250.8 Mio. EUR |
| 2.17 |
| -34.42% |
| 10.91% |
| - |
| - |
| - |
| - |
| MODERNA |
| 04.05.26 |
|